Article Data

  • Views 190
  • Dowloads 117

Retracted of European Journal of Gynaecological Oncology. 2025. 46(5)

Retractions

Open Access

Retraction: Diagnostic value of transvaginal ultrasound combined with serum CA125 and HE4 in differentiating benign and malignant ovarian tumors

  • European Journal of Gynaecological Oncology Editorial Office1,*,

1MRE Press No. 50 Tagore Lane, 03-01 (H), 787494 Singapore, Singapore

DOI: 10.22514/ejgo.2026.020 Vol.47,Issue 2,April 2026 pp.60-60

Published: 15 April 2026

*Corresponding Author(s): European Journal of Gynaecological Oncology Editorial Office E-mail: editor@ejgo.net

Abstract

Post-publication, an investigation initiated by editorial team identified that a large proportion of the references cited in the article [1] have low relevance or no direct connection to the study’s methods, results, or discussion. This extensive use of irrelevant citations undermines the academic rigor and reliability of the published work. The article is therefore retracted. The authors did not respond with the retraction.

The journal apologizes to its readers for any inconvenience caused.


Cite and Share

European Journal of Gynaecological Oncology Editorial Office. Retraction: Diagnostic value of transvaginal ultrasound combined with serum CA125 and HE4 in differentiating benign and malignant ovarian tumors. European Journal of Gynaecological Oncology. 2026. 47(2);60-60.

References

[1] Liu XX, Han Y. Diagnostic value of transvaginal ultrasound combined with serum CA125 and HE4 in differentiating benign and malignant ovarian tumors. European Journal of Gynaecological Oncology. 2025; 46: 130–137.


Submission Turnaround Time

Top